Bindinglaw

US · guidance

CMS SOM App. C, Tag D2098

§493.843 Standard: Endocrinology

activein force · 2026-07-22 – presentas-observed

Refer to Subpart I for analytes or tests for which laboratory PT performance is to be

evaluated, which include serum, plasma, blood, or urine.

NOTE: If the laboratory performs the same analyte on different specimen types, it may

choose which specimen type to enroll in PT. The laboratory need not enroll for each

specimen type of the same analyte. The laboratory is required to perform twice a year

verification of accuracy for the test not enrolled for PT. (See §493.1236/D5217)

(a) Failure to attain a score of at least 80 percent of acceptable responses for each

analyte in each testing event is unsatisfactory analyte performance for the testing

event.

History

Rev. 233; Issued: 09-12-25; Effective: 09-12-25; Implementation: 09-12-25

Provenance

Source
cms.gov
Retrieved
2026-07-22
Edition
som-2026-07-22
Content hash
8394d1fd8f196e7e5d2d90bf2944b98d3bf3c45cafc0f96ad6fd7a38cb7a194a
View the official source →

The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.

Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.

Coverage · API docs

Bindinglaw

Point-in-time US law with the receipt attached. Source URL, retrieval time, content hash, and validity dates on every answer.

curl api.binding.law/v1/law/coverage

© 2026 binding.law · a Jubal, Inc. productAttorneys and firms never pay. Ever.